劲方医药-B（02595）今日盘中大涨10.92%，引起市场广泛关注。该股近期表现强劲，投资者情绪高涨。
消息面上，香港联交所最新资料显示，9月23日，劲方医药-B股东将价值4.37亿港元的股票由中信证券经纪香港转入渣打银行（香港），占公司股份的3.42%。这一大规模转仓行为可能被市场解读为机构投资者对公司前景的信心，从而推动股价上涨。
值得注意的是，劲方医药-B于9月19日在港交所首次公开招股（IPO），上市首日表现亮眼，盘中最高涨幅达146.20%，收盘大涨106.47%，市值接近150亿港元。公司主要专注于肿瘤以及自体免疫和炎症性疾病领域的新疗法开发，目前拥有8款候选产品，其中5款已进入临床开发阶段。公司的业务重点和研发管线或许也是投资者看好其未来发展前景的原因之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.